Cannabinoid Control of Fear Extinction Neural Circuits in Post-traumatic Stress Disorder
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 26 Apr 2019
Price : $35 *
At a glance
- Drugs Dronabinol (Primary)
- Indications Post-traumatic stress disorders
- Focus Pharmacodynamics; Therapeutic Use
- 23 Apr 2019 Planned primary completion date changed from 1 Mar 2019 to 1 Dec 2019.
- 23 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 30 Apr 2018 Planned End Date changed from 1 Mar 2018 to 1 Dec 2019.